Eli Lilly and Company
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. David A. Ricks
- Full Time Employees
- 43,000
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Address
- Lilly Corporate Center Indianapolis IN United States of America 46285
- IPO Date
- Jun 1, 1972
- CIK
- 0000059478
- Website
- lilly.com
- Similar Companies
- Business
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Company News
FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Warning: This Skyrocketing Stock Has a Hidden Risk
Here's Why Eli Lilly (LLY) Fell More Than Broader Market
2 No-Brainer Dividend Growth Stocks to Buy Right Now
NVS or LLY: Which Is the Better Value Stock Right Now?
LLY Stock Rises on Congressional Budget Office Report
Why Eli Lilly Was Such a Healthy Stock Today
Qinotto and Lilly Enter Research Collaboration and License Agreement
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
LLY: Legal Battle Over FDA's Decision on Eli Lilly's Weight Loss Drug
Billion-Dollar News for Eli Lilly Stock Investors
Compounding group sues FDA for removing Lilly's weight loss drug from shortage list
5 Large Drug Stocks to Watch From a Thriving Industry
2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now
Concerns Over Muscle Loss with GLP-1 Weight Loss Drugs (LLY, NVO, REGN)
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
The Big 3: LLY, CVX, RBLX
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over